A team of researchers from the Netherlands, Germany and the U.S. reports that two drugs show promise in rejuvenating lung epithelial progenitor cells damaged by chronic obstructive pulmonary disease (COPD). In their study, ...
A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threatening symptoms ...
Mar 23, 2022
0
126
Chronic obstructive pulmonary disease—COPD for short—is one of the most common diseases of the lung. It affects almost 300 million people worldwide, of which about three million die every year. A collective term for chronic ...
Jan 14, 2022
0
19
The global burden of Chronic Obstructive Pulmonary Disease (COPD), a group of common lung conditions that affects more than 300 million people, could be significantly reduced with a simple health assessment, concludes a large-scale ...
Jan 11, 2022
0
50
In 2019, the WHO positioned chronic obstructive pulmonary disease (COPD) third in the global ranking of causes of death. However, some mechanisms of this debilitating chronic respiratory disease are yet to be identified. ...
Dec 14, 2021
0
65
Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive ...
Nov 24, 2021
0
159
Researchers working with primary care patients in China have discovered that a simple questionnaire and airflow measurement test could identify adults suffering with undiagnosed chronic obstructive pulmonary disease (COPD), ...
Oct 5, 2021
0
12
Chronic obstructive pulmonary disease (COPD) causes illness and death worldwide. It is characterized by destruction of the walls of tiny air sacs in the lungs—known as emphysema—and a decline in lung function. Little ...
Jul 19, 2021
0
93
The results of a study by an international scientific team co-led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that—like pouring water atop a wellhead before pumping—the ...
Jul 14, 2021
0
19
Scientists from Hokkaido University have discovered a novel defensive response to SARS-CoV-2 that involves the viral pattern recognition receptor RIG-I. Upregulating expression of this protein could strengthen the immune ...
May 21, 2021
0
63
